Table 1.
Potential impact of understanding functional T cell lineages in GCA
A. | Diagnostics |
Determine T cell frequencies in diagnostic work-up | |
Monitor T cell frequencies as a marker of disease activity | |
Evaluate type and frequency of tissue-infiltrating T cells | |
Example: IL-17-producing patients with MS are non-responders to IFN-β Tx | |
B. | Therapeutics |
Block T cell cytokine to disrupt inflammatory end pathway | |
Target antigen-presenting cells to inhibit T cell differentiation | |
Interrupt T cell recruitment to vessel wall or in situ activation | |
Example: Therapeutic anti-IL-17 antibodies in Rheumatoid Arthritis | |
C. | Pathogenic concepts |
Use disease-relevant T cells as a tool to identify the disease instigator(s) | |
Separate GCA from other disease processes | |
Example: Chromogranin-specific T cells cause islet cell destruction and diabetes |